Impact News +++ Stolt-Nielsen GAAP EPS of $0.89, revenue of $716.8M; withdraws FY26 outlook (SeekingAlpha) +++ STOLT-NIELSEN Aktie -3,33%

CORCEPT THERAPEUTICS Aktie

>Aktienkurs

35.785 EUR (TradegateBSX)

Ask: 36.14 EUR / 276 Stück

Bid: 35.43 EUR / 282 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>Performance

1 Woche: -0,5%

1 Monat: +26,5%

3 Monate: +14,6%

6 Monate: -50,9%

1 Jahr: -43,0%

laufendes Jahr: -46,9%

>CORCEPT THERAPEUTICS Aktie

Name:

CORCEPT THERAPEUTICS INC.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US2183521028 / 529882

Symbol/ Ticker:

HTD (Frankfurt) / CORT (NASDAQ)

Kürzel:

FRA:HTD, ETR:HTD, HTD:GR, NASDAQ:CORT

Index:

Webseite:

https://www.corcept.com/

Profil:

Corcept Therapeutics Incorporated is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing drugs that modulate cortisol effects to treat severe endocrinologic, metabolic, oncologic, and neurologic disorders..
>Volltext..

Marktkapitalisierung:

3721.28 Mio. EUR

Unternehmenswert:

3413.26 Mio. EUR

Umsatz:

652.05 Mio. EUR

EBITDA:

39.98 Mio. EUR

Nettogewinn:

84.06 Mio. EUR

Gewinn je Aktie:

0.81 EUR

Schulden:

5.23 Mio. EUR

Liquide Mittel:

103.19 Mio. EUR

Operativer Cashflow:

121.6 Mio. EUR

Bargeldquote:

2.24

Umsatzwachstum:

-0.58%

Gewinnwachstum:

-38.07%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

3 Insider kauften innerhalb der letzten 30 Tage Aktien im Wert von 1.578.253 USD.

Suchwörter:

CORCEPT THERAPEUTICS, CORCEPT THERAPEUTIC

Letzte Datenerhebung:

09.04.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 106.37 Mio. St.

Frei handelbar: 88.11%

Leerverk. Aktien: 12.25%

Rückkaufquote: 3.39%

Mitarbeiter: 730

Umsatz/Mitarb.: 0.89 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 56.63%

Bewertung:

KGV: 53.22

KGV lG: 113.8

KUV: 5.94

KBV: 7.12

PEG-Ratio: -

EV/EBITDA: 85.37

Rentabilität:

Bruttomarge: 98.3%

Gewinnmarge: 12.89%

Operative Marge: 5.88%

Managementeffizenz:

Gesamtkaprendite: 11.7%

Eigenkaprendite: 14.79%

>Peer Group

Gesundheit, Lebererkrankungen & -behandlung/ Hepatitis, Diabetes- & Adipositas- Behandlung

>Chart & Kurs - NASDAQ

>Alle News

09.04.26 - 07:01	Insiderhandel: Chief Development Officer verkauft Aktien von Corcept Therapeutics im Wert von 819400 USD (Insiderkauf)
	Guyer, William - Vorstand - Tag der Transaktion: 2026-04-07...

07.04.26 - 18:18	Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman (PR Newswire)
	CORT Investors with Losses Encouraged to Contact Firm SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending......

07.04.26 - 18:03	Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
	BENSALEM, Pa., April 7, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). IF YOU......

07.04.26 - 09:45	CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, April 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21,......

06.04.26 - 18:03	Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
	LOS ANGELES, April 6, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN......

06.04.26 - 18:03	CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
	LOS ANGELES, April 6, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the......

06.04.26 - 10:01	Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT (PR Newswire)
	LOS ANGELES, April 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5......

04.04.26 - 02:54	Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT (PR Newswire)
	NEW ORLEANS, April 3, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics Incorporated (NasdaqCM: CORT)......

04.04.26 - 00:31	Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman (PR Newswire)
	SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending securities class action is April 21, 2026. The firm urges......

01.04.26 - 21:24	Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman (PR Newswire)
	SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending securities class action is April 21, 2026. The firm urges......

31.03.26 - 23:18	CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, March 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April......

31.03.26 - 18:03	Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
	LOS ANGELES, March 31, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). IF YOU SUFFERED A......

30.03.26 - 22:01	CORT INVESTOR ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss (PR Newswire)
	Lawsuit Alleges Management Concealed Repeated FDA Warnings Regarding Insufficient Data While Touting Pipeline Readiness; Firm Reminds Investors of April 21 Deadline SAN FRANCISCO, March 30, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in......

30.03.26 - 10:12	Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT (PR Newswire)
	LOS ANGELES, March 30, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5......

30.03.26 - 10:12	CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
	LOS ANGELES, March 30, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the......

28.03.26 - 03:27	Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC (PR Newswire)
	NEW YORK and NEW ORLEANS, March 27, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until April 21, 2026 to file lead plaintiff applications in a......

28.03.26 - 01:00	Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week (Fool)
	It was a historic stretch of time for the biotech....

28.03.26 - 00:01	Insiderhandel: Chief Executive Officer verkauft Aktien von Corcept Therapeutics im Wert von 1311826 USD (Insiderkauf)
	Belanoff, Joseph K. - Vorstand - Tag der Transaktion: 2026-03-25...

27.03.26 - 16:36	Weekly Buzz: Corcept Therapeutics Wins FDA Nod In Cancer; Merck & Co. Acquires Terns Pharmaceuticals; Insmed Meets Trial Goals But Valneva Misses (AFX)
	KENILWORTH (NJ) (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Japan, EU withdrawals, mergers, and clinical trial data readouts spanning lung disease,......

27.03.26 - 04:06	CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, March 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wenn jedoch die Kraft, die die menschliche Aktivität bestimmt, nicht die Vernunft ist, bleibt der Mensch unter dem Niveau seiner eigenen Möglichkeiten. - Robert Strange McNamara

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram